Profil
Ryan Crowe is currently SVP-Investor Relations & Strategic Analysis at Regeneron Pharmaceuticals, Inc. since 2022.
Formerly, Mr. Crowe was Senior Director-Investor Relations at Pfizer Inc. and Vice President-Investor Relations at Myovant Sciences Ltd. Education includes an undergraduate degree from Drexel University and an MBA from The Leonard N Stern School of Business.
Postes actifs de Ryan Crowe
| Sociétés | Poste | Début |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Investor Relations Contact | 01/01/2022 |
Anciens postes connus de Ryan Crowe
| Sociétés | Poste | Fin |
|---|---|---|
| MYOVANT SCIENCES LTD. | Investor Relations Contact | - |
| PFIZER INC. | Public Communications Contact | - |
Formation de Ryan Crowe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Drexel University
Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myovant Sciences Ltd.
Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
















